Protocol for a randomized controlled trial comparing a very low-carbohydrate diet or moderate-carbohydrate plate-method diet for type 2 diabetes: the LEGEND (Lifestyle Education about Nutrition for Diabetes) trial

被引:0
作者
Saslow, Laura R. [1 ]
Eslamian, Adriana [2 ]
Moran, Patricia [2 ]
Hartogensis, Wendy [2 ]
Mason, Ashley E. [2 ]
Kim, Sarah [2 ]
Bauer, Douglas C. [2 ]
Griauzde, Dina Hafez [1 ]
Goldman, Veronica [2 ]
Liu, Vivian [2 ]
Stephens, Pam [1 ]
Raymond, Kate [1 ]
Yeung, George [2 ]
Leung, Cindy [3 ]
Hecht, Frederick M. [2 ]
机构
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] Univ Calif San Francisco, San Francisco, CA USA
[3] Harvard Univ, Cambridge, MA USA
关键词
Type; 2; diabetes; Glycemic control; Lifestyle intervention; Randomized controlled trial; WEIGHT-LOSS; PRELIMINARY VALIDATION; NLRP3; INFLAMMASOME; HEALTH; QUESTIONNAIRE; OUTCOMES; THERAPY; ADULTS;
D O I
10.1186/s13063-023-07512-9
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
BackgroundOptimal carbohydrate intake is an important and controversial area in the nutritional management of type 2 diabetes. Some evidence indicates that reducing overall carbohydrate intake with a low- or very low-carbohydrate eating plan can improve glycemic control compared to following eating plans that involve greater carbohydrate intake. However, critical knowledge gaps currently prevent clear recommendations about carbohydrate intake levels.MethodsThe LEGEND (Lifestyle Education about Nutrition for Diabetes) Trial aims to compare a very low-carbohydrate diet to a moderate-carbohydrate plate-method diet for glycemic control in adults with type 2 diabetes. This two-site trial plans to recruit 180 adults with type 2 diabetes. We will randomize participants to either a 20-session group-based diet and lifestyle intervention that teaches either a very low-carbohydrate diet or a moderate-carbohydrate plate-method diet. We will assess participants at study entry and 4 and 12 months later. The primary outcome is HbA1c, and secondary outcomes include inflammation (high sensitivity C-reactive protein), body weight, changes in diabetes medications, lipids (small particle LDL, HDL, triglycerides), skeletal metabolism (bone mineral density from dual-energy x-ray absorptiometry and bone turnover markers serum procollagen type I N propeptide and serum C-terminal telopeptide of type I collagen), and body composition (percent body fat, percent lean body mass).DiscussionThe LEGEND trial is a randomized controlled trial to assess optimal carbohydrate intake in type 2 diabetes by evaluating the effects of a very low-carbohydrate diet vs. a moderate-carbohydrate plate-method diet over a year-long period. The research addresses important gaps in the evidence base for the nutritional management of type 2 diabetes by providing data on potential benefits and adverse effects of different levels of carbohydrate intake.
引用
收藏
页数:15
相关论文
共 45 条
  • [1] Clinical associations of an updated medication effect score for measuring diabetes treatment intensity
    Alexopoulos, Anastasia-Stefania
    Yancy, William S.
    Edelman, David
    Coffman, Cynthia J.
    Jeffreys, Amy S.
    Maciejewski, Matthew L.
    Voils, Corrine, I
    Sagalla, Nicole
    Bradley, Anna Barton
    Dar, Moahad
    Mayer, Stephanie B.
    Crowley, Matthew J.
    [J]. CHRONIC ILLNESS, 2021, 17 (04) : 451 - 462
  • [2] American Diabetes Association, 2020, WHAT IS DIAB PLAT ME
  • [3] American Diabetes Association, OUR MEAL PLANS
  • [4] Fruit and vegetable consumption and health outcomes: an umbrella review of observational studies
    Angelino, Donato
    Godos, Justyna
    Ghelfi, Francesca
    Tieri, Maria
    Titta, Lucilla
    Lafranconi, Alessandra
    Marventano, Stefano
    Alonzo, Elena
    Gambera, Angelo
    Sciacca, Salvatore
    Buscemi, Silvio
    Ray, Sumantra
    Galvano, Fabio
    Del Rio, Daniele
    Grosso, Giuseppe
    [J]. INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION, 2019, 70 (06) : 652 - 667
  • [5] Long-Term Effects of a Novel Continuous Remote Care Intervention Including Nutritional Ketosis for the Management of Type 2 Diabetes: A 2-Year Non-randomized Clinical Trial
    Athinarayanan, Shaminie J.
    Adams, Rebecca N.
    Hallberg, Sarah J.
    McKenzie, Amy L.
    Bhanpuri, Nasir H.
    Campbell, Wayne W.
    Volek, Jeff S.
    Phinney, Stephen D.
    McCarter, James P.
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2019, 10
  • [6] National Bone Health Alliance Bone Turnover Marker Project: current practices and the need for US harmonization, standardization, and common reference ranges
    Bauer, D.
    Krege, J.
    Lane, N.
    Leary, E.
    Libanati, C.
    Miller, P.
    Myers, G.
    Silverman, S.
    Vesper, H. W.
    Lee, D.
    Payette, M.
    Randall, S.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2012, 23 (10) : 2425 - 2433
  • [7] Progressive bone mineral content loss in children with intractable epilepsy treated with the ketogenic diet
    Bergqvist, A. G. Christina
    Schall, Joan I.
    Stallings, Virginia A.
    Zemel, Babette S.
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2008, 88 (06) : 1678 - 1684
  • [8] Cardiovascular disease risk factor responses to a type 2 diabetes care model including nutritional ketosis induced by sustained carbohydrate restriction at 1 year: an open label, non-randomized, controlled study
    Bhanpuri, Nasir H.
    Hallberg, Sarah J.
    Williams, Paul T.
    McKenzie, Amy L.
    Ballard, Kevin D.
    Campbell, Wayne W.
    McCarter, James P.
    Phinney, Stephen D.
    Volek, Jeff S.
    [J]. CARDIOVASCULAR DIABETOLOGY, 2018, 17
  • [9] Effects of a Low Carbohydrate Weight Loss Diet on Exercise Capacity and Tolerance in Obese Subjects
    Brinkworth, Grant D.
    Noakes, Manny
    Clifton, Peter M.
    Buckley, Jonathan D.
    [J]. OBESITY, 2009, 17 (10) : 1916 - 1923
  • [10] Appendicular lean mass and mortality among prefrail and frail older adults
    Brown, J. C.
    Harhay, M. O.
    Harhay, M. N.
    [J]. JOURNAL OF NUTRITION HEALTH & AGING, 2017, 21 (03) : 342 - 345